Health-related quality of life outcomes in patients with active ankylosing spondylitis treated with adalimumab: results from a randomized controlled study.
about
Physical function, disease activity, and health-related quality-of-life outcomes after 3 years of adalimumab treatment in patients with ankylosing spondylitisTNF-alpha inhibitors for ankylosing spondylitisAdalimumab in ankylosing spondylitis: an evidence-based review of its place in therapy.Treatment of ankylosing spondylitis with TNF blockers: a meta-analysis.Psychometric characteristics of the short form 36 health survey and functional assessment of chronic illness Therapy-Fatigue subscale for patients with ankylosing spondylitis.Maintenance of improvement in spinal mobility, physical function and quality of life in patients with ankylosing spondylitis after 5 years in a clinical trial of adalimumabASAS40 and ASDAS clinical responses in the ABILITY-1 clinical trial translate to meaningful improvements in physical function, health-related quality of life and work productivity in patients with non-radiographic axial spondyloarthritis.Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial.The joint-gut axis in inflammatory bowel diseases.Efficacy and safety of adalimumab treatment in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis.Update of the literature review on treatment with biologics as a basis for the first update of the ASAS/EULAR management recommendations of ankylosing spondylitis.Adalimumab for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis - a five-year update.Randomized, placebo controlled and double-blind trials of efficacy and safety of adalimumab for treating ankylosing spondylitis: a meta-analysis.Bioboosters in the treatment of rheumatic diseases: a comprehensive review of currently available biologics in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis.Efficacy and safety of adalimumab in ankylosing spondylitis.Adaptation of Chinese and English versions of the Ankylosing Spondylitis quality of life (ASQoL) scale for use in SingaporeNeurological Complications of Therapeutic Monoclonal Antibodies: Trends from Oncology to Rheumatology."Better but not best": a qualitative exploration of the experiences of occupational gain for people with inflammatory arthritis receiving anti-TNFα treatment.[German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 8.4 Pharmaceutical therapy, 8.5 Evaluation of therapy success of pharmaceutical measures].
P2860
Q21195369-DC0DAD6D-EDCC-494B-908A-E837317DFBF4Q24186462-A5D03517-59D2-48A3-A5C3-F459DB258B7EQ34449888-C34532F9-EE90-4B89-9F29-72DCBED1DEB4Q34728162-80820E81-C5EF-4F75-B6AF-B8CB621E01BDQ35071645-A6F19EB6-1C8C-4D52-B6C5-2C35313D8C63Q35759171-554352D0-6CF9-4496-9FA1-692567FCD704Q36366162-2ADE309D-0C8A-4F87-8924-70B5F8EBAD57Q37172795-3D8D3AD9-0196-478B-8615-DBC21139C2BAQ37814551-7017AFBF-CAB5-4386-9DD6-D26000B85B59Q37873493-438724D6-8E98-42B6-9D0D-646FDA005003Q37994661-07DB414C-9732-4DEA-A724-7468919CDABCQ38145501-5FEA5491-2EF2-4BCB-84A1-F59DB056E6D4Q38186145-36539944-F65B-436B-98F7-585D49BFDFFAQ38993250-F0273F93-6C28-4B93-B562-3FA2497ACA69Q38993324-14788B45-F559-42A2-9A5A-FFBD27E6E236Q41451166-EF79A16E-B7B9-44A5-8818-37D8AE643092Q52541392-E651AE93-C015-4892-9A13-443381FCDCFFQ52652457-8B1F5B07-3929-4CEE-BC84-F853124DC1E7Q52874129-48CB92EF-C193-4275-B8C2-CD07115F5596
P2860
Health-related quality of life outcomes in patients with active ankylosing spondylitis treated with adalimumab: results from a randomized controlled study.
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Health-related quality of life ...... a randomized controlled study.
@ast
Health-related quality of life ...... a randomized controlled study.
@en
Health-related quality of life ...... a randomized controlled study.
@nl
type
label
Health-related quality of life ...... a randomized controlled study.
@ast
Health-related quality of life ...... a randomized controlled study.
@en
Health-related quality of life ...... a randomized controlled study.
@nl
prefLabel
Health-related quality of life ...... a randomized controlled study.
@ast
Health-related quality of life ...... a randomized controlled study.
@en
Health-related quality of life ...... a randomized controlled study.
@nl
P2093
P356
P1476
Health-related quality of life ...... a randomized controlled study.
@en
P2093
Anne M Rentz
Dennis Revicki
Désirée M F van der Heijde
Hartmut Kupper
John C Davis
Michelle P Luo
Robert L Wong
P304
P356
10.1002/ART.22887
P577
2007-08-01T00:00:00Z